AVE 0.00% 0.3¢ avecho biotechnology limited

incredible, page-17

  1. 379 Posts.
    Last post, as I've nailed my flag, but Dhukka's fair point merits a, I hope considered, reply.

    No problem with a cap raising. Nice if there had been a thumping upfront - perhaps rather encouraged by all the reports emanating from the company on discussions with all & sundry - but there we go. The concern is simply what it's for & what it can achieve.

    The company's going it alone in a major launch seems unbelievable. The cash usage must be substantial & in any launch would need to be sustained for some time. They carry no serious marketing expertise and a skelton staff.

    The rest to spent on Oxy development will still leave it a long way from completion.

    Looks as if the launch is a last throw for the old regime. I hope the company will give a serious - credible? - explanation of its current reasoning when it announces the funding
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $182 60.5K

Buyers (Bids)

No. Vol. Price($)
49 88052619 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 60223414 21
View Market Depth
Last trade - 10.00am 20/08/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.